RTTNews | Jun 23, 2021 08:36AM EDT

08:36 Wednesday, June 23, 2021 (RTTNews) - Genprex:Phase 1/2 Acclaim-1 Trial Begun For REQORSA Immunogene Therapy With Tagrisso To Treat NSCLC Following FDA Review

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved